Once-Weekly Semaglutide
Semaglutide is a once-weekly GLP-1 receptor agonist studied for blood-sugar management and weight reduction, helping regulate appetite with meaningful, sustained results in clinical trials.
Semaglutide is a once-weekly GLP-1 receptor agonist studied for blood-sugar management and weight reduction, helping regulate appetite with meaningful, sustained results in clinical trials.